Site Search

Share

X

Search Results

State Policy Principles to Support Access to Biomarker Testing

...                                                                                               Biomarker testing is available for an ever-increasing range of conditions and diseases. Data shows that patients receiving targeted treatments, also known as ... – a roadmap for working with state policymakers to advance solutions that reduce barriers to access and promote patient outcomes.  What is Biomarker Testing? Biomarkers are an essential part of precision medicine providing necessary information for appropriate therapeutic intervention. ...

Rhode Island Senate Votes to Remove Barriers to Biomarker Testing

PROVIDENCE –Today, the Rhode Island Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Dubbed ‘the right treatment, to the right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes – biomarker testing being one of the ways we can achieve these outcomes by allowing doctors to understand and target unique markers in a patient’s ...

Biomarker Testing Bill Passes Senate Committee, Advances to Senate Floor

Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration. Biomarker testing is a precision medicine tool that utilizes information from patients’ disease cells to determine the right treatment at the ...

Senate & House Vote Unanimously to Increase Access to Biomarker Testing

HARTFORD – May 21, 2025 – Earlier today, the Connecticut Senate voted in unanimous support of legislation that would ensure biomarker testing is covered by state regulated insurance plans, including Medicaid, when supported by scientific and medical evidence. This vote comes on ... (ACS CAN) in Connecticut: “We are thrilled to see back-to-back unanimous votes from the Senate and House in support of increased access to biomarker testing. Expanding access to this form of precision medicine will help more people in Connecticut get the right treatment at the right ...

Gov. Moore Approves Legislation to Expand Access to Biomarker Testing

... Gov. Wes Moore will be signing HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at 12:00pm in the State ... champions who saw HB 1217 / SB 805 to the finish line. For more information on precision medicine, cancer biomarkers, current barriers to biomarker testing and ACS CAN’s policy recommendations, visit:  www.fightcancer.org/biomarkers . ###  About ACS CAN The American Cancer Society ...

State Biomarker Coverage Laws

Advancements in biomarker testing have transformed cancer treatment, improving survival and quality of life by connecting patients with the therapies most likely to benefit ... them, and coverage of these tests is essential to ensuring access to precision treatments. This white paper highlights the importance of state biomarker coverage laws and offers recommendations to expand access to testing. State Biomarker Coverage Laws ...

Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing

Pharmacogenomic (PGx) testing (also known as pharmacogenomic biomarker testing) is a component of precision medicine that involves examining a patient’s inherited genes to detect variations that may impact the way a ... treatment given to patients with the same disease can produce different responses based on each person's inherited genes. Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing ...

Bill Increasing Access to Biomarker Testing for Certain Coloradans Becomes Law

... law during a ceremony at the Governor’s Mansion on Monday afternoon, ensuring more Colorado patients with private insurance have coverage for biomarker testing . The American Cancer Society Cancer Action Network (ACS CAN) recognizes the signing of the bill as a positive first step to increasing access to biomarker testing to connect patients with the right treatment at the right time. During Monday’s ceremony, Governor Polis was surrounded by ...

Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment

... to support ACS CAN’s advocacy work at all levels of government. Fielded September 12-25, 2023, our latest survey explores experiences with biomarker testing. The web-based survey was conducted among 1,222n cancer patients and survivors nationwide who have been diagnosed with or treated for cancer in the last seven years. Summary of Findings Higher Income and Education Groups are Most Likely to Report Having and Asking for Biomarker Testing About half (49%) of those surveyed have had biomarker testing for their cancer, while 29% say they have not and 22% are unsure. ...

Tennessee Senate Passes Biomarker Testing Coverage Bill, Sending to Governor's Desk

NASHVILLE, Tenn. – The Tennessee Senate unanimously passed a bill to expand coverage of biomarker testing on Thursday, April 16, sending it to the desk of Gov. Bill Lee. SB0435 would expand coverage of biomarker testing for patients enrolled in state employee health insurance plans and TennCare. The Senate unanimously passed SB0435 with 30 votes. ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy